Search research articles
Contact Us
Filters
Showing results (561-570 of 721) with videos related to
Page
of 73
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 16, 2020
Intraoperative <sup>68</sup>Ga-PSMA Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Feasibility Study
Christopher Darr, Nina N Harke, Jan Philipp Radtke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 22, 2022
Joint EANM, SNMMI, and IAEA Enabling Guide: How to Set up a Theranostics Center
Ken Herrmann, Luca Giovanella, Andrea Santos, et al.
Radiation Oncology (London, England)
|
September 16, 2021
Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and <sup>18</sup>F-FDG PET/CT for radiotherapy target volume definition
Maja Guberina, Kaid Darwiche, Hubertus Hautzel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 15, 2018
Potential Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer
Jeremie Calais, Amar U Kishan, Minsong Cao, et al.
Cancers
|
November 26, 2022
PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study
Susanna Mattoni, Andrea Farolfi, Fabio Formaggio, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 15, 2022
Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study
Andrei Gafita, Isabel Rauscher, Manuel Weber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2024
<sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy
Helena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2021
PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY
Maja Guberina, Christoph Poettgen, Martin Metzenmacher, et al.
Cancers
|
March 28, 2024
Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment-Comparison with Stage III Disease
Maja Guberina, Christoph Pöttgen, Nika Guberina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 24, 2016
Radiation Dosimetry for <sup>177</sup>Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions
Shozo Okamoto, Anne Thieme, Jakob Allmann, et al.
Page
of 73
Search research articles
Search
Showing results (561-570 of 721) with videos related to
Sort By:
Page
of 73
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 16, 2020
Intraoperative <sup>68</sup>Ga-PSMA Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Feasibility Study
Christopher Darr, Nina N Harke, Jan Philipp Radtke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 22, 2022
Joint EANM, SNMMI, and IAEA Enabling Guide: How to Set up a Theranostics Center
Ken Herrmann, Luca Giovanella, Andrea Santos, et al.
Radiation Oncology (London, England)
|
September 16, 2021
Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and <sup>18</sup>F-FDG PET/CT for radiotherapy target volume definition
Maja Guberina, Kaid Darwiche, Hubertus Hautzel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 15, 2018
Potential Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer
Jeremie Calais, Amar U Kishan, Minsong Cao, et al.
Cancers
|
November 26, 2022
PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study
Susanna Mattoni, Andrea Farolfi, Fabio Formaggio, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 15, 2022
Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study
Andrei Gafita, Isabel Rauscher, Manuel Weber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2024
<sup>68</sup>Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy
Helena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2021
PROGNOSTIC VALUE OF POST-INDUCTION CHEMOTHERAPY VOLUMETRIC PET/CT PARAMETERS FOR STAGE IIIA/B NON-SMALL CELL LUNG CANCER PATIENTS RECEIVING DEFINITIVE CHEMORADIOTHERAPY
Maja Guberina, Christoph Poettgen, Martin Metzenmacher, et al.
Cancers
|
March 28, 2024
Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment-Comparison with Stage III Disease
Maja Guberina, Christoph Pöttgen, Nika Guberina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 24, 2016
Radiation Dosimetry for <sup>177</sup>Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions
Shozo Okamoto, Anne Thieme, Jakob Allmann, et al.
Page
of 73